leisure time -WSS

leisure time

author：entertainment 2025-08-24 04:06:28 - browse：166

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： How Robert F. Kennedy Jr. distorted vaccine science

WSS

STAT wants to know your pick for a great summer read or listen

Maui funeral service workers on devastation of fires: 'I'm in shock'

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

Skip the lead apron during X

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

focus

leisure time

knowledge

Trump demands the U.S. pay no more for drugs than other countries … again

Skip the lead apron during X

Sports medicine is finally prioritizing gender equality

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Tori Bowie and the unacceptable rates of Black maternal death

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Medicare details structure of new drug price negotiation program

Maui funeral service workers on devastation of fires: 'I'm in shock'

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

GOP presidential candidates start declaring their loyalty

knowledge

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Covid's long

A letter from the executive editor: The 2023 STATUS List

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Where are patients getting their prescriptions for GLP

Genentech weighs delaying cancer therapy after drug pricing law

explore

focus

Wikipedia

focus